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Recent studies highlight other, nonho-
meostatic controls of feeding related
to food reward and learning. The ques-
tion is whether the regions highlighted
in these studies should be considered
as functionally apart from or interacting
with homeostatic controls.
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FoxO3 regulates the transcription of critical components of the ubiquitin-proteasome system in
muscle wasting. Two reports (Mammucari et al., 2007; Zhao et al., 2007) now implicate FoxO3 in
the transcription of autophagy-related genes and provide the first direct evidence for a coordinated
role of autophagy in muscle atrophy.Skeletal muscle exhibits high plasticity
and is themajor protein reservoir in the
body. Muscle proteins can be mobi-
lized into free amino acids upon disuse
or inactivity, in fasting, and in numer-
ous pathological states (trauma, burn
injury, cancer cachexia, AIDS, sepsis,
diabetes, renal failure, etc.) pending
enhanced proteolysis. In the short
term, this adaptation is highly benefi-
cial: amino acids are used to provide
energy, as precursors of acute-phase
protein synthesis in the liver, and to
maintain protein synthesis in obliga-
tory working organs (e.g., heart, brain,
and lungs). By contrast, sustained
muscle wasting is highly detrimental
and results in prolonged hospitali-
zation. The ability of the organism to
recover from pathologies is rapidly
impaired, and loss of strength ulti-
mately results in increased morbidity
and mortality. Therefore, understand-
ing the mechanisms responsible for
muscle wasting is of major clinicalimportance and is a critical issue in
terms of health care costs (Attaix
et al., 2005). In this issue ofCell Metab-
olism, Zhao et al. (2007) and Mammu-
cari et al. (2007) provide central new in-
sights into a signaling pathway that
coordinates proteolytic systems in
atrophying muscles.
The activation of the ubiquitin-
proteasome system is widely believed
to be responsible for muscle wasting,
and numerous groups have reported
a negligible role of the lysosomal sys-
tem in this adaptation. Nonetheless,
differential display analyses initially
led to the identification of cathepsin
L mRNA as being overexpressed in
atrophyingmuscles fromseptic and tu-
mor-bearing rats (Deval et al., 2001).
Compared to other proteases, cathep-
sin L is induced early in catabolic
states, correlates with enhanced
proteolysis, and is responsive to both
catabolic and anticatabolic stimuli.
Thorough microarray analyses furtherCell Metabolism 6, Didentified a set of atrophy-specific
genes (‘‘atrogenes’’) that are differen-
tially expressed in various models of
muscle atrophy (Lecker et al., 2004).
Atrogenes encompass the ubiquitin li-
gases MAFbx/atrogin-1 and MuRF1,
which seemcritical in ubiquitin-protea-
some proteolysis, and also cathepsin L
and proteins important for autophagy.
While cathepsins determine the pro-
teolytic capacity of lysosomes, au-
tophagy is required to drive substrates
to lysosomes, and additional observa-
tions have emphasized the importance
of this process in muscle. First, au-
tophagy does occur in cultured myo-
tubes and is critical for the amino
acid-dependent regulation of proteol-
ysis (Mordier et al., 2000). Second,
there is direct evidence for impaired ly-
sosomal function and autophagy in
various myopathies (Bechet et al.,
2005). Third, to investigate autophagy
in vivo, Mizushima et al. (2004) gener-
ated transgenic mice expressing theecember 2007 ª2007 Elsevier Inc. 425
Cell Metabolism
Previewsautophagy (Atg) protein LC3/Atg8
fused to green fluorescent protein,
and they observed a clear induction
of autophagy in the muscles of starved
mice. Muscle autophagy is fiber type
specific, and autophagosomes are lo-
cated in the perinuclear region and
even between myofibrils. Remarkably,
and in contrast to other tissues, mus-
cles generate mostly small autopha-
gosomes, which certainly accounts
for previous difficulties in identifying
these structures in this tissue.
Now, Zhao et al. (2007) and Mam-
mucari et al. (2007) elegantly put for-
ward the significance of the lysosomal
system for muscle proteolysis and fur-
ther unravel a novel signaling pathway
critical for muscle autophagy. PI3K/
Akt promotes protein synthesis by
stimulating translation via mTOR and
conversely inhibits proteolysis via two
parallel pathways. The first involves
the inhibition by Akt of FoxO-depen-
dent transcription of MAFbx/atrogin-1
andMuRF1 and ubiquitin-proteasome
proteolysis (Sandri et al., 2004) (Fig-
ure 1). The second implicates mTOR,426 Cell Metabolism 6, December 2007 ªwhich is widely accepted as central
for the downregulation of autophagy,
although alternative pathways prevail
in muscle cells (Tassa et al., 2003).
Herein, Zhao et al. (2007) further inves-
tigate the mechanisms involved and
surprisingly find that lysosomal autoph-
agy, but not proteasomes, mainly con-
tributes to FoxO3 stimulation of prote-
olysis in myotubes. In the companion
paper, Mammucari et al. (2007) exam-
ine the signaling pathways regulating
muscle autophagy and unexpectedly
report that mTOR is dispensable for
regulating muscle autophagy in vivo.
Both reports converge to underline
that FoxO3 is critical for the transcrip-
tional regulation of autophagy-related
genes (Figure 1).
Atg proteins, together with their
regulating factors, act in a concerted
series of posttranslational modifica-
tions to generate double-membrane
autophagosomes, which transfer their
contents to lysosomes. In mammalian
cells, the regulatory mechanisms typi-
cally involve reshapingofAtgposttrans-
lational modifications, but transcrip-2007 Elsevier Inc.tional regulations of Atg genes were
barely underlined prior to these studies.
According to the cell type and stage of
differentiation, various combinations of
signaling pathways (mTOR, class III
PI3K, p38) regulate autophagy via
transcription-independentmechanisms
soon after nutrient or insulin/IGF-1 dep-
rivation (Meijer andCodogno, 2006). By
contrast, the two new papers strongly
suggest that in the long term, a stimu-
lation of transcription is necessary to
maintain an active Atg machinery.
Using gain-of-function and loss-
of-function approaches, Zhao et al.
(2007) and Mammucari et al. (2007)
clearly demonstrate that FoxO3 in-
duces autophagy and is unique in its
capacity to stimulate expression of
many Atg genes in myotubes, in iso-
lated muscle fibers, and in muscle
in vivo. The authors verify that dener-
vation and starvation, either of which
activates FoxO3 in atrophying mus-
cles, also induce autophagy genes.
The two groups further demonstrate
that this transcriptional regulation in-
volves the direct binding of FoxO3 toFigure 1. Overview of the Coordinate Transcriptional Regulation of Autophagy and Proteasomal Proteolysis by FoxO3
Activation of Akt downstream of growth factors, such as IGF-1 or insulin, involves class I PI3K. Akt increases signaling through mTOR, which stim-
ulates translation and inhibits autophagy. Nontranscriptional regulation of autophagy also involves class III PI3K, Erk1/2 kinases, or p38MAPK. Akt
further phosphorylates FoxO3, leading to its exclusion from the nucleus and inhibition of its transcriptional functions. Dephosphorylated FoxO3
stimulates the transcription of MAFbx/atrogin-1 and MuRF1 to enhance proteasomal proteolysis, and transcription of autophagy-related genes
(LC3, Atg12, Atg4, Beclin1, Gabarapl1, Ulk2, Bnip3, and Bnip3l) to increase autophagy and lysosomal proteolysis. Arrows indicate positive inputs,
whereas lines ending with a bar indicate inhibitory inputs.
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Previewsspecific sites in promoters of autoph-
agy-related genes and that fasting in-
deed increases such FoxO3 binding.
Conversely, the authors provide con-
vincing evidence that knockdown of
FoxO3 prevents starvation-induced
autophagy in isolated fibers and in
muscle in vivo.
Mammucari et al. (2007) further in-
vestigate themechanisms of this regu-
lation and discover that Bnip3, whose
transcription is controlled by FoxO3,
plays a major role in mediating the ef-
fects of FoxO3 and starvation on au-
tophagy. Bnip3 was previously found
to induce autophagy in cardiac myo-
cytes, where strikingly, this regulation
depends on Bnip3 localization to the
mitochondrial outer membrane (Ha-
macher-Brady et al., 2007). Further re-
search is therefore required to sort out
how much autophagy is induced as
a consequence of the mitochondrial
functions of Bnip3. Nonetheless, the
relevance of autophagy to muscle
physiology is undoubtedly empha-
sized by the observation that knock-Mitochondria and
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Metabolic component depletion i
difficult to reconcile with human
that mitochondrial electron transp
dent, providing an alternative view
Mitochondria not only are the ‘‘power-
houses of the cell’’ but also contribute
to numerous cellular functions, includ-
ing generation of free radicals, apopto-
sis, calcium signaling, and at least in
the wormC. elegans, aging. Abnormal-
ities in these dynamic organelles are
also associated with various human
metabolic diseases. The discrepancies
between human metabolic disorders
and the phenotypes displayed bydown of Atg8/LC3 partly reducesmus-
cle atrophy.
Together, these findings demon-
strate that FoxO3 directly and coor-
dinately activates the lysosomal and
proteasomal pathways inmusclewast-
ing. Critical proteins targeted for break-
down by either system remain to be
identified. Whether FoxO3 may control
alternative proteolytic routes (e.g., cal-
pains and caspases) that also seem to
be important in muscle wasting re-
mains to be determined.REFERENCES
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an extension, which has been
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(atp-2(ua2), nuo-1(ua1)) to short-lived
(mev-1(kn1), gas-1(fc21)) to long-lived
(clk-1(qm30), isp-1(qm150)) (Rea, 2005).
Worms treated with RNAi against nu-
merous different nuclear-encoded mi-
tochondrial ETC and ATP synthase
genes often exhibit lengthened life
span (Dillin et al., 2002; Lee et al.,
2003; Curran and Ruvkun, 2007;
Chen et al., 2007). Rea et al. (2007) at-
tempt to resolve the disparity between
ecember 2007 ª2007 Elsevier Inc. 427
